CoronaVirusU.SWorld

FDA advisory panel rejects widespread Pfizer booster shots

The vote Friday, 61-3, was a blow to the Biden administration's effort to shore up people's protection against the virus amid the highly contagious delta variant.

An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.

The vote Friday, 61-3, was a blow to the Biden administration’s effort to shore up people’s protection against the virus amid the highly contagious delta variant.

Over several hours of discussion, members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses.

And they complained that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the US experience.

ALSO READ  New Zealand hits virus high, pushes vaccination as way out

Get more stories like this on InstagramTelegram and Whatsapp



NewsWestAfricans

NewsWestAfricans


All Right Reserved. This material and any other digital content on this platform may not be reproduced, Published, Written or Distributed in full or in part, Without Written Permission from NEWS WESTAFRICANS Media.

Leave a Reply

Your email address will not be published.

Back to top button

Adblock Detected

Please turn off the Ad Blocker from your browser to continue browsing our site.